Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.
Provided By GlobeNewswire
Last update: Apr 10, 2025
Industry leader in the development and application of cellular therapies, including CAR NK products, for cancer
Led development of multiple clinical candidates from conception through IND and early clinical development
Read more at globenewswire.com
